Effectiveness of an evidence-based care pathway to improve mobility and participation in older patients with vertigo and balance disorders in primary care (MobilE-PHY2): A multicentre cluster-randomised controlled trial

Not Applicable

Conditions: R42
H81
R26
R29.6
F45.8
Dizziness and giddiness
Disorders of vestibular function
Abnormalities of gait and mobility
Tendency to fall, not elsewhere classified
Other somatoform disorders

Registration Number: DRKS00028524

Lead Sponsor: Technische Hochschule Rosenheim, Fakultät für Angewandte Gesundheits- und Sozialwissenschaften

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Enrolling by invitation

Sex: All

Target Recruitment: 120

Inclusion Criteria

At least 60 years old
- Consulted GP with recent or chronic complaints of VDB
- Ability to stand up on their own
- Ability to stand for two minutes with support

Exclusion Criteria

- DHI score less than 12 points
- Moderate to severe cognitive impairments measured by the Mini-Mental State Examination (MMST) with an cut off less than 20 points
- Presence of psychiatric disorders (ICD-10: F10, F19, F20, F29, F30, F31, F32.2, F32.3, F32.8, F32.9, F33.2, F33.3, F33.8, F33.9)
- Limited life expectancy (= 1 year) due to an advanced disease with a poor prognosis
- VDB caused by actual substance abuse
- Inability to complete questionnaires and follow instructions because of insufficient command of the German language

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome is the impact of VDB on participation and mobility of patients after six month follow-up, assessed using the Dizziness Handicap Inventory (DHI). The primary outcome will be assessed on patient level in the intervention group and control group at three measurement points: At baseline after randomisation (t0), after four months (t1) and after six months (t2).

Secondary Outcome Measures